MCL coexpression mm9:1088: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 6: | Line 6: | ||
|ontology_enrichment_disease= | |ontology_enrichment_disease= | ||
|ontology_enrichment_uberon=UBERON:0000160!5.95e-17!31;UBERON:0005409!2.43e-15!47;UBERON:0009854!1.29e-12!23;UBERON:0009856!1.29e-12!23;UBERON:0001007!1.49e-12!116;UBERON:0001555!1.49e-12!116;UBERON:0007026!1.49e-12!116;UBERON:0004119!1.50e-12!118;UBERON:0000925!1.50e-12!118;UBERON:0006595!1.50e-12!118;UBERON:0002107!4.65e-12!22;UBERON:0007499!4.65e-12!22;UBERON:0006925!4.65e-12!22;UBERON:0009497!4.65e-12!22;UBERON:0000015!4.65e-12!22;UBERON:0002423!4.65e-12!22;UBERON:0006235!4.65e-12!22;UBERON:0008835!4.65e-12!22;UBERON:0003894!4.65e-12!22;UBERON:0004161!4.65e-12!22;UBERON:0008836!4.65e-12!22;UBERON:0004921!1.45e-11!114;UBERON:0005172!1.57e-10!49;UBERON:0005173!1.57e-10!49;UBERON:0002417!1.57e-10!49;UBERON:0000916!1.57e-10!49;UBERON:0002365!9.15e-10!25;UBERON:0002330!9.15e-10!25;UBERON:0000344!1.45e-08!15;UBERON:0009569!1.47e-07!66;UBERON:0001242!2.52e-07!13;UBERON:0000060!2.52e-07!13;UBERON:0001262!2.52e-07!13;UBERON:0004786!2.52e-07!13 | |ontology_enrichment_uberon=UBERON:0000160!5.95e-17!31;UBERON:0005409!2.43e-15!47;UBERON:0009854!1.29e-12!23;UBERON:0009856!1.29e-12!23;UBERON:0001007!1.49e-12!116;UBERON:0001555!1.49e-12!116;UBERON:0007026!1.49e-12!116;UBERON:0004119!1.50e-12!118;UBERON:0000925!1.50e-12!118;UBERON:0006595!1.50e-12!118;UBERON:0002107!4.65e-12!22;UBERON:0007499!4.65e-12!22;UBERON:0006925!4.65e-12!22;UBERON:0009497!4.65e-12!22;UBERON:0000015!4.65e-12!22;UBERON:0002423!4.65e-12!22;UBERON:0006235!4.65e-12!22;UBERON:0008835!4.65e-12!22;UBERON:0003894!4.65e-12!22;UBERON:0004161!4.65e-12!22;UBERON:0008836!4.65e-12!22;UBERON:0004921!1.45e-11!114;UBERON:0005172!1.57e-10!49;UBERON:0005173!1.57e-10!49;UBERON:0002417!1.57e-10!49;UBERON:0000916!1.57e-10!49;UBERON:0002365!9.15e-10!25;UBERON:0002330!9.15e-10!25;UBERON:0000344!1.45e-08!15;UBERON:0009569!1.47e-07!66;UBERON:0001242!2.52e-07!13;UBERON:0000060!2.52e-07!13;UBERON:0001262!2.52e-07!13;UBERON:0004786!2.52e-07!13 | ||
|tfbs_overrepresentation_for_novel_motifs=0.438063,0.161863,0.411716,1.20801,0.810002,1.23933,0.587291,0.594722,0.616096,0.478312,0.542749,1.40872,0.206435,0.599731,0.847296,0,0.795315,0.291368,0.19222,0.112498,0.374752,0.27937,0.598814,0.80655,0.419327,0.62766,0.184473,0.516511,0.344372,0.145661,1.25421,0.897561,0.78719,0.166577,0.316253,0.0235321,1.40094,0.57142,0.258564,0.230656,0.800988,0.507468,0.258106,0.851774,0.277561,0.469348,0.714592,0.532496,0.219744,0.917701,0.777641,0.654933,0.139618,1.04034,1.0579,0.606984,0.356236,0.56214,0.522357,0.604914,0.877332,0.664501,0.642748,0.766235,0.618279,0.807219,1.19497,1.54543,0.872612,1.39786,1.79967,0.608073,0.293368,1.09164,1.55661,0.159969,0.498755,0.703064,0.859987,0.378988,0.610783,0.812889,0.663039,0.200155,0.975495,0.146394,0.042613,0.145788,0.719558,1.70793,1.26498,0.980512,0.910485,0.305079,0.254625,0.237542,0.203879,0.913319,0.71485,0.399703,0.280055,0.897279,1.02279,0.778243,0.777175,0.507021,0.837607,0.528416,0.383871,0.376549,1.10097,1.02459,0.380122,1.35148,1.27206,0.293461,0.418498,0.484437,0.796633,0.276329,1.09707,0.745011,0.629509,0.702145,1.32639,0.863723,0.595563,0.903645,1.19345,0.308038,1.00568,0.473246,1.16374,0.620831,1.29374,0.275843,1.13474,0.508896,1.24438,2.07659,1.67603,1.19971,0.641722,0.908128,0.770616,0.507927,0.717753,2.03691,0.448938,0.300961,0.147909,0.545091,1.04192,0.243291,0.619892,1.12411,0.655955,0.327731,0.435579,0.446272,1.25393,0.974632,0.864173,0.428662,0.767269,0.612377,0.278874,2.40184,0.227149 | |||
}} | }} |
Revision as of 19:22, 26 November 2012
Phase1 CAGE Peaks
Short description | |
---|---|
Mm9::chr11:73139974..73139980,- | p2@Aspa |
Mm9::chr5:87995134..87995144,- | p@chr5:87995134..87995144 - |
Mm9::chr5:87997964..87997976,- | p3@Sult1d1 |
Mm9::chr5:87997991..87998003,- | p4@Sult1d1 |
Mm9::chr5:87998007..87998027,- | p2@Sult1d1 |
Mm9::chrX:83021894..83021919,- | p2@Gyk |
Mm9::chrX:83021945..83021982,- | p1@Gyk |
Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data
GO ID | GO name | FDR corrected p-value |
---|---|---|
GO:0009068 | aspartate family amino acid catabolic process | 0.00291129926721968 |
GO:0006533 | aspartate catabolic process | 0.00291129926721968 |
GO:0006083 | acetate metabolic process | 0.00291129926721968 |
GO:0017067 | tyrosine-ester sulfotransferase activity | 0.00291129926721968 |
GO:0019807 | aspartoacylase activity | 0.00291129926721968 |
GO:0004370 | glycerol kinase activity | 0.00291129926721968 |
GO:0006531 | aspartate metabolic process | 0.00291129926721968 |
GO:0004046 | aminoacylase activity | 0.00370488396178192 |
GO:0004062 | aryl sulfotransferase activity | 0.00370488396178192 |
GO:0006791 | sulfur utilization | 0.00370488396178192 |
GO:0000103 | sulfate assimilation | 0.00370488396178192 |
GO:0006072 | glycerol-3-phosphate metabolic process | 0.00509365721805264 |
GO:0009066 | aspartate family amino acid metabolic process | 0.0109661455256367 |
GO:0006071 | glycerol metabolic process | 0.0135726686781398 |
GO:0019751 | polyol metabolic process | 0.0135726686781398 |
GO:0008146 | sulfotransferase activity | 0.0270918119405119 |
GO:0009063 | amino acid catabolic process | 0.0270918119405119 |
GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides | 0.0270918119405119 |
GO:0016782 | transferase activity, transferring sulfur-containing groups | 0.0270918119405119 |
GO:0009310 | amine catabolic process | 0.0270918119405119 |
GO:0044270 | nitrogen compound catabolic process | 0.0270918119405119 |
GO:0006790 | sulfur metabolic process | 0.0277014569550259 |
GO:0016810 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds | 0.0396802049783122 |
Relative expression of the co-expression cluster over median <br>Analyst:
Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br><br>uberon_data<br><br>
Ontology term | p-value | n |
---|---|---|
intestine | 5.95e-17 | 31 |
gastrointestinal system | 2.43e-15 | 47 |
digestive tract diverticulum | 1.29e-12 | 23 |
sac | 1.29e-12 | 23 |
digestive system | 1.49e-12 | 116 |
digestive tract | 1.49e-12 | 116 |
primitive gut | 1.49e-12 | 116 |
endoderm-derived structure | 1.50e-12 | 118 |
endoderm | 1.50e-12 | 118 |
presumptive endoderm | 1.50e-12 | 118 |
liver | 4.65e-12 | 22 |
epithelial sac | 4.65e-12 | 22 |
digestive gland | 4.65e-12 | 22 |
epithelium of foregut-midgut junction | 4.65e-12 | 22 |
anatomical boundary | 4.65e-12 | 22 |
hepatobiliary system | 4.65e-12 | 22 |
foregut-midgut junction | 4.65e-12 | 22 |
hepatic diverticulum | 4.65e-12 | 22 |
liver primordium | 4.65e-12 | 22 |
septum transversum | 4.65e-12 | 22 |
liver bud | 4.65e-12 | 22 |
subdivision of digestive tract | 1.45e-11 | 114 |
abdomen element | 1.57e-10 | 49 |
abdominal segment element | 1.57e-10 | 49 |
abdominal segment of trunk | 1.57e-10 | 49 |
abdomen | 1.57e-10 | 49 |
exocrine gland | 9.15e-10 | 25 |
exocrine system | 9.15e-10 | 25 |
mucosa | 1.45e-08 | 15 |
subdivision of trunk | 1.47e-07 | 66 |
intestinal mucosa | 2.52e-07 | 13 |
anatomical wall | 2.52e-07 | 13 |
wall of intestine | 2.52e-07 | 13 |
gastrointestinal system mucosa | 2.52e-07 | 13 |
TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data
Novel motifs
JASPAR motifs
Motifs | -log10(p-value) |
---|---|
{{{tfbs_overrepresentation_jaspar}}} |